Incyte Corporation NDCs and Package Codes
This page lists NDC package records associated with labeler code 73535 (Incyte Corporation) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.
Key stats
1
Package NDCs
1
Products
1
Active listings
0
Discontinued
1
Ingredients
0
Therapeutic classes
1
Dosage forms
0
With NADAC pricing
Portfolio
Top ingredients
By dosage form
Browse records — 1 product
| Drug / product | Billing NDC | NADAC / unit | Status | |
|---|---|---|---|---|
| MONJUVI Tafasitamab-cxix 200 mg/5mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 73535-0208-01 | — | On market | View → |
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.